Literature DB >> 36203650

Precision Medicine for Obesity.

Lizeth Cifuentes1, Maria Daniela Hurtado A1,2, Jeanette Eckel-Passow3, Andres Acosta1.   

Abstract

Obesity is a multifactorial disease with a variable and underwhelming weight loss response to current treatment approaches. Precision medicine proposes a new paradigm to improve disease classification based on the premise of human heterogeneity, with the ultimate goal of maximizing treatment effectiveness, tolerability, and safety. Recent advances in high-throughput biochemical assays have contributed to the partial characterization of obesity's pathophysiology, as well as to the understanding of the role that intrinsic and environmental factors, and their interaction, play in its development and progression. These data have led to the development of biological markers that either are being or will be incorporated into strategies to develop personalized lines of treatment for obesity. There are currently many ongoing initiatives aimed at this; however, much needs to be resolved before precision obesity medicine becomes common practice. This review aims to provide a perspective on the currently available data of high-throughput technologies to treat obesity.

Entities:  

Keywords:  ADOPT; genetics; microbiome; phenotypes

Year:  2021        PMID: 36203650      PMCID: PMC9534386          DOI: 10.1055/s-0041-1729945

Source DB:  PubMed          Journal:  Dig Dis Interv        ISSN: 2472-8721


  126 in total

Review 1.  Dietary factors, epigenetic modifications and obesity outcomes: progresses and perspectives.

Authors:  F I Milagro; M L Mansego; C De Miguel; J A Martínez
Journal:  Mol Aspects Med       Date:  2012-07-04

2.  Comparison of 4 diets of varying glycemic load on weight loss and cardiovascular risk reduction in overweight and obese young adults: a randomized controlled trial.

Authors:  Joanna McMillan-Price; Peter Petocz; Fiona Atkinson; Kathleen O'neill; Samir Samman; Katherine Steinbeck; Ian Caterson; Jennie Brand-Miller
Journal:  Arch Intern Med       Date:  2006-07-24

3.  A new initiative on precision medicine.

Authors:  Francis S Collins; Harold Varmus
Journal:  N Engl J Med       Date:  2015-01-30       Impact factor: 91.245

Review 4.  Insights into the multifactorial causation of obesity by integrated genetic and epigenetic analysis.

Authors:  Sara Diels; Wim Vanden Berghe; Wim Van Hul
Journal:  Obes Rev       Date:  2020-03-14       Impact factor: 9.213

5.  Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials.

Authors:  Karine Clément; Erica van den Akker; Jesús Argente; Allison Bahm; Wendy K Chung; Hillori Connors; Kathleen De Waele; I Sadaf Farooqi; Julie Gonneau-Lejeune; Gregory Gordon; Katja Kohlsdorf; Christine Poitou; Lia Puder; James Swain; Murray Stewart; Guojun Yuan; Martin Wabitsch; Peter Kühnen
Journal:  Lancet Diabetes Endocrinol       Date:  2020-10-30       Impact factor: 32.069

6.  Allelic variant in the glucagon-like peptide 1 receptor gene associated with greater effect of liraglutide and exenatide on gastric emptying: A pilot pharmacogenetics study.

Authors:  V Chedid; P Vijayvargiya; P Carlson; K Van Malderen; A Acosta; A Zinsmeister; M Camilleri
Journal:  Neurogastroenterol Motil       Date:  2018-02-28       Impact factor: 3.598

Review 7.  Genetic factors in human obesity.

Authors:  I S Farooqi; S O'Rahilly
Journal:  Obes Rev       Date:  2007-03       Impact factor: 9.213

8.  An analysis of DNA methylation in human adipose tissue reveals differential modification of obesity genes before and after gastric bypass and weight loss.

Authors:  Miles C Benton; Alice Johnstone; David Eccles; Brennan Harmon; Mark T Hayes; Rod A Lea; Lyn Griffiths; Eric P Hoffman; Richard S Stubbs; Donia Macartney-Coxson
Journal:  Genome Biol       Date:  2015-01-22       Impact factor: 13.583

9.  Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency.

Authors:  Tinh-Hai Collet; Béatrice Dubern; Jacek Mokrosinski; Hillori Connors; Julia M Keogh; Edson Mendes de Oliveira; Elana Henning; Christine Poitou-Bernert; Jean-Michel Oppert; Patrick Tounian; Florence Marchelli; Rohia Alili; Johanne Le Beyec; Dominique Pépin; Jean-Marc Lacorte; Andrew Gottesdiener; Rebecca Bounds; Shubh Sharma; Cathy Folster; Bart Henderson; Stephen O'Rahilly; Elizabeth Stoner; Keith Gottesdiener; Brandon L Panaro; Roger D Cone; Karine Clément; I Sadaf Farooqi; Lex H T Van der Ploeg
Journal:  Mol Metab       Date:  2017-07-08       Impact factor: 7.422

Review 10.  Multi-omics approaches to disease.

Authors:  Yehudit Hasin; Marcus Seldin; Aldons Lusis
Journal:  Genome Biol       Date:  2017-05-05       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.